Literature DB >> 27510251

SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a South Indian population.

K Ramesh1, A K Hemanth Kumar1, T Kannan1, R Vijayalakshmi1, V Sudha1, S Manohar Nesakumar1, T Bharathiraja1, J Lavanya2, S Swaminathan1, G Ramachandran1.   

Abstract

OBJECTIVE: To determine the effect of SLCO1B1 gene polymorphisms (rs11045819, rs4149032 and rs4149033) on rifampicin (RMP) concentrations in adult tuberculosis (TB) patients from south India.
METHODS: We genotyped adult TB patients for three SLCO1B1 gene polymorphisms-rs11045819, rs4149032 and rs4149033-and compared 2-h post-dosing RMP concentrations of the different genotypes for each of the polymorphisms. Plasma RMP was determined using high-performance liquid chromatography. Genotyping was performed using direct sequencing.
RESULTS: Among the 256 study patients, minor allele frequencies were respectively 0.01 (A), 0.46 (C) and 0.07 (A) for rs11045819, rs4149032 and rs4149033 polymorphisms; genotype distributions followed Hardy-Weinberg equilibrium. RMP concentrations did not significantly differ between the different genotypes of the three polymorphisms.
CONCLUSION: This is the first study to show that rs11045819, rs4149032 and rs4149033 polymorphisms in the SLCO1B1 gene did not influence RMP concentrations in Indian patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27510251     DOI: 10.5588/ijtld.15.1007

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

Review 2.  Pharmacokinetics of First-Line Anti-Tubercular Drugs.

Authors:  Aparna Mukherjee; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2019-03-26       Impact factor: 1.967

3.  Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.

Authors:  Geetha Ramachandran; Hemanth Kumar Agibothu Kupparam; Chandrasekaran Vedhachalam; Kannan Thiruvengadam; Vijayalakshmi Rajagandhi; Azger Dusthackeer; Ramesh Karunaianantham; Lavanya Jayapal; Soumya Swaminathan
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis.

Authors:  Albert Dompreh; Xiaoli Tang; Jianlin Zhou; Hongmei Yang; Ariel Topletz; Eugene Adu Ahwireng; Sampson Antwi; Antony Enimil; Taimour Langaee; Charles A Peloquin; Michael H Court; Awewura Kwara
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 5.  Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review.

Authors:  Tesemma Sileshi; Gosaye Mekonen; Eyasu Makonnen; Eleni Aklillu
Journal:  Pharmgenomics Pers Med       Date:  2022-06-04

6.  Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.

Authors:  Anushka Naidoo; Maxwell Chirehwa; Veron Ramsuran; Helen McIlleron; Kogieleum Naidoo; Nonhlanhla Yende-Zuma; Ravesh Singh; Sinaye Ncgapu; John Adamson; Katya Govender; Paolo Denti; Nesri Padayatchi
Journal:  Pharmacogenomics       Date:  2019-02-15       Impact factor: 2.638

7.  Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.

Authors:  Derek J Sloan; Andrew D McCallum; Alessandro Schipani; Deirdre Egan; Henry C Mwandumba; Steve A Ward; David Waterhouse; Gertrude Banda; Theresa J Allain; Andrew Owen; Saye H Khoo; Geraint R Davies
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 8.  Genetic Diversity in Drug Transporters: Impact in African Populations.

Authors:  Iris Rajman; Laura Knapp; Imad Hanna
Journal:  Clin Transl Sci       Date:  2020-03-31       Impact factor: 4.689

Review 9.  Highlights on the Application of Genomics and Bioinformatics in the Fight Against Infectious Diseases: Challenges and Opportunities in Africa.

Authors:  Saikou Y Bah; Collins Misita Morang'a; Jonas A Kengne-Ouafo; Lucas Amenga-Etego; Gordon A Awandare
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 10.  The importance of clinical pharmacokinetic-pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomes.

Authors:  Andrew D McCallum; Derek J Sloan
Journal:  Int J Pharmacokinet       Date:  2017-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.